Tuesday , January 31 2023

Recent Posts

Bioventure, Minapharm Pharmaceuticals, and MiGenTra Sign an Exclusive Agreement for the Commercialization of Multiple Biosimilar Candidates of Alvotech in the Middle East and Africa

  Bioventure, a Dubai-based pharmaceutical company, Minapharm Pharmaceuticals, a Cairo-based pharmaceutical company, and MiGenTra GmbH , a Berlin-based pharmaceutical company, announced today the signing of an exclusive license agreement for the commercialization of multiple biosimilar candidates developed and manufactured by Alvotech, in Egypt and eighteen additional countries in Africa and …

Read More »

Strong Recommendation for Pyronaridine-Artesunate in Revised World Health Organization (WHO) Malaria Treatment Guidelines

The WHO’s Guidelines for the Treatment of Malaria are the standard reference that guides country-level policies for managing malaria. New medicines are only recommended for inclusion following a robust and in-depth evaluation of evidence using the GRADE framework, which provides a systematic approach to making clinical practice recommendations. Following this …

Read More »

Seplat Energy Becomes First Nigerian company to earn ISO 55001:2014 Asset Management System Certification

Seplat Energy Plc, a leading Nigerian independent energy company listed on both the Nigerian Exchange Limited and the London Stock Exchange, announces that it has successfully obtained the ISO 55001:2014 Standard Asset Management System certification, becoming the first energy company in Africa to achieve this remarkable feat. ISO 55001 is the international …

Read More »